IP Library › Granted Patent US 7,098,003
Granted Patent B2
US 7,098,003 · App. 10/147,485 · Granted Aug 29, 2006

PRO 1384 nucleic acids

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,098,003
App. No.
10/147,485
Granted
Aug 29, 2006
Kind
B2
Abstract

The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

Claims (44)

1. An isolated nucleic acid encoding a polypeptide having at least 95% sequence identity to:

(a) the amino acid sequence of the polypeptide of SEQ ID NO:522;

(b) the amino acid sequence of the polypeptide of SEQ ID NO:522, lacking its associated signal peptide;

(c) the amino acid sequence of the extracellular domain of the polypeptide of SEQ ID NO:522;

(d) the amino acid sequence of the polypeptide encoded by the nucleic acid sequence of SEQ IDNO:521;

(e) the amino acid sequence of the polypeptide encoded by the full-length coding sequence of the nucleic acid sequence of SEQ ID NO:521 or

(f) the amino acid sequence of the polypeptide encoded by the full-length coding sequence of the cDNA deposited under ATCC accession number 203135;

wherein said polypeptide induces chondrocyte re-differentiation.

2. The isolated nucleic acid of claim 1 encoding a polypeptide having at least 99% sequence identity to:

(a) the amino acid sequence of the polypeptide of SEQ ID NO:522;

(b) the amino acid sequence of the polypeptide of SEQ ID NO:522, lacking its associated signal peptide;

(c) the amino acid sequence of the extracellular domain of the polypeptide of SEQ ID NO:522;

(d) the amino acid sequence of the polypeptide encoded by the nucleic acid sequence of SEQ ID NO:521;

(e) the amino acid sequence of the polypeptide encoded by the full-length coding sequence of the nucleic acid sequence of SEQ ID NO:521 or

(f) the amino acid sequence of the polypeptide encoded by the full-length coding sequence of the cDNA deposited under ATCC accession number 203135;

wherein said polypeptide induces chondrocyte re-differentiation.

3. A vector comprising the nucleic acid of claim 1 .

4. The vector of claim 3 , wherein said nucleic acid is operably linked to control sequences recognized by a host cell transformed with the vector.

5. An isolated host cell comprising the vector of claim 1 .

6. The host cell of claim 5 , wherein said cell is a CHO cell, an E. coli or a yeast cell.

7. An isolated nucleic acid comprising:

(a) a nucleic acid sequence encoding the polypeptide of SEQ ID NO:522;

(b) a nucleic acid sequence encoding the polypeptide of SEQ ID NO:522, lacking its associated signal peptide;

(c) a nucleic acid sequence encoding the extracellular domain of the polypeptide of SEQ ID NO:522;

(d) the nucleic acid sequence of SEQ ID NO:521;

(e) the full-length coding sequence of the nucleic acid sequence of SEQ ID NO:521; or

(f) the full-length coding sequence of the cDNA deposited under ATCC accession number 203135.

8. The isolated nucleic acid of claim 7 comprising a nucleic acid sequence encoding the polypeptide of SEQ ID NO:522.

9. The isolated nucleic acid of claim 1 comprising a nucleic acid sequence encoding the polypeptide of SEQ ID NO:522, lacking its associated signal peptide.

10. The isolated nucleic acid of claim 1 comprising a nucleic acid sequence encoding the extracellular domain of the polypeptide of SEQ ID NO:522.

11. The isolated nucleic acid of claim 1 comprising the nucleic acid sequence of SEQ ID NO:521.

12. The isolated nucleic acid of claim 1 comprising the full-length coding sequence of the nucleic acid sequence of SEQ ID NO:521.

13. The isolated nucleic acid of claim 1 comprising the full-length coding sequence of the cDNA deposited under ATCC accession number 203135.

14. A vector comprising the nucleic acid of claim 1 .

15. The vector of claim 14 , wherein said nucleic acid is operably linked to control sequences recognized by a host cell transformed with the vector.

16. An isolated host cell comprising the vector of claim 14 .

17. The host cell of claim 16 , wherein said cell is a CHO cell, an E. coli or a yeast cell.

18. An isolated nucleic acid molecule consisting of an at least 350 nucleotide fragment of the nucleic acid sequence of SEQ ID NO:521, or a complement thereof, that specifically hybridizes under stringent conditions to:

(a) the nucleic acid sequence of SEQ ID NO:521 or a complement thereof;

(b) the full-length coding sequence of the nucleic acid sequence of SEQ ID NO:521 or a complement thereof; or

(c) the full-length coding sequence of the cDNA deposited under ATCC accession number 203135 or a complement thereof;

and wherein said stringent conditions are 50% fomiamide, 5×SSC (0.75 M NaCl, 0.075 M sodium citrate), 50 mM sodium phosphate (pH 6.8), 0.1% sodium pyrophosphate, 5× Denhardt's solution, sonicated salmon sperm DNA (50 μg/ml), 0.1% SDS, and 10% dextran sulfate at 42° C., with washes at 42° C. in 0.2×SSC (sodium chloride/sodium citrate), followed by a high-stringency wash at 55° C. in 0.1×SSC containing EDTA.

19. The isolated nucleic acid of claim 18 , which is at least 400 nucleotides or above in length.

20. The isolated nucleic acid of claim 18 which is at least 450 nucleotides or above in length.